The role of systematic data reviews in safety assessment of infant nutrition

Annals of Nutrition and Metabolism

Volumn 60, Issue 3, 2012, Pages 204-207

  Szajewska, Hania ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Adverse effects; Pediatrics; Safety; Systematic review; Tolerance

Indexed keywords

DATA ANALYSIS; DECISION MAKING; EVIDENCE BASED MEDICINE; HUMAN; INFANT NUTRITION; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SAFETY; SYSTEMATIC REVIEW (TOPIC);

BIAS (EPIDEMIOLOGY); CLINICAL TRIALS AS TOPIC; FOOD ADDITIVES; FOOD SAFETY; HUMANS; INFANT; INFANT FORMULA; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INFANT, NEWBORN; INFANT, PREMATURE; MEDLINE; PROBIOTICS; PROTEIN HYDROLYSATES; REVIEW LITERATURE AS TOPIC;

EID: 84862491431     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000338339     Document Type: Review

References (11)

1. Higgins JP, Green S (eds): Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated September 2008). The Cochrane Collaboration, 2008. www.cochrane-handbook.org.
2. Ioannidis JP, Evans SJ, Gøtzsche PC, O'Neill RT, Altman DG, Schulz K, Moher D; CONSORT Group: Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med 2004; 141: 781-788. (Pubitemid 39524916)
3. Loke YK, Price D, Herxheimer A; on behalf of the Cochrane Adverse Effects Methods Group: in Higgins JP, Green S (eds): Cochrane Handbook for Systematic Reviews of Interventions. Wiley-Blackwell, 2009, pp 433-447.
4. Golder S, Loke Y, McIntosh HM: Room for improvement? A survey of the methods used in systematic reviews of adverse effects. BMC Med Res Methodol 2006;6:3.
5. Braegger C, Chmielewska A, Decsi T, Kolacek S, Mihatsch W, Moreno L, Pieścik M, Puntis J, Shamir R, Szajewska H, Turck D, van Goudoever J; ESPGHAN Committee on Nutrition: Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition. J Pediatr Gastroenterol Nutr 2011; 52: 238-250.
6. Loke YK: Assessing the benefit-harm balance at the bedside. BMJ 2004; 329: 7-8.
7. Loke YK, Golder SP, Vandenbroucke JP: Comprehensive evaluations of the adverse effects of drugs: importance of appropriate study selection and data sources. Ther Adv Drug Saf 2011; 2: 59-68.
8. Golder S, Loke YK, Bland M: Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview. PLoS Med 2011; 8:e1001026.
9. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E: Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004; 363: 1341-1345.
10. Dinnes J, Sowden AJ, Deeks J, Altman D: A review of quality assessment tools for non-randomised intervention studies. Annual Meeting of the International Society of Technology Assessment in Health Care. Philadelphia, 2001.
11. https://www.cebp.nl/media/m69.pdf (accessed on 3 May 2011).